Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: -5.00 (-2.94%)
Spread: 10.00 (6.25%)
Open: 170.00
High: 170.00
Low: 165.00
Prev. Close: 170.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Fundraising

7 Oct 2020 07:00

RNS Number : 3026B
Helios Underwriting Plc
07 October 2020
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN HELIOS UNDERWRITING PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT DECISION IN RESPECT OF HELIOS UNDERWRITING PLC.

MEMBERS OF THE PUBLIC SHALL NOT BE ELIGIBLE TO TAKE PART IN THE PROPOSED FUNDRASING, WHICH IS TO BE LIMITED TO PERSONS WHO: (i) HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS WITHIN THE MEANING OF ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005 (THE "ORDER"); OR (ii) ARE PERSONS WITHIN ARTICLE 49(2)(A) TO (D) ("HIGH NET WORTH COMPANIES, UNINCORPORATED ASSOCIATIONS ETC.") OF THE ORDER; OR (iii) ARE PERSONS WITHIN ARTICLE 50 ("SOPHISTICATED INVESTORS") OF THE ORDER; OR (iv) ARE PERSONS WITHIN ARTICLE 51 ("ASSOCIATIONS OF HIGH NET WORTH OR SOPHISTICATED INVESTORS") OF THE ORDER; OR (v) ARE PERSONS WHO MIGHT OTHERWISE BE LAWFULLY ENTITLED TO PARTICIPATE IN THE FUNDRAISING. 

 

 

FOR IMMEDIATE RELEASE

7 October 2020

 

Helios Underwriting plc

("Helios" or the "Company")

 

Proposed Fundraising

 

Further to its announcement of 10 August 2020 (the "Announcement"), Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's, confirms that the Board is considering a fundraising to raise £20.0 million through the issue of new ordinary shares in the Company ("New Shares") to take advantage of the attractive opportunities for growth and shareholder value enhancement in the hardening market (the "Fundraising"). The Company currently has indications of interest for the substantial part of the Fundraising, including sizeable orders from insurance specialist institutional investors.

 

The discussions with potential investors have crystallised around an issue price of 120 pence per share ("Issue Price"), being a discount of approximately 42 per cent. to adjusted net asset value ("ANAV"), but a premium of approximately 25 per cent. to the closing mid-market price on 6 October 2020. An issue at this price and to raise no more than £20 million will limit the dilution to existing shareholders' ANAV per share, whilst allowing the Company to raise the necessary firepower to finance the additional capital required to fund the increase in the Company's capacity from pre-emptions, make further LLV acquisitions, to increase Helios' retained capacity and to participate in upcoming capacity auctions. The Fundraising is expected to be subject to shareholder approval.

 

As part of the Fundraising, the Company intends to enter into conditional agreements with Nigel Hanbury, Chief Executive of the Company, and Arthur Manners, Chief Financial Officer of the Company, to acquire an LLV from each of them for a combined consideration of £5.5 million, being a 21 per cent. discount to their Humphrey valuation of approximately £7.0 million, expected to be satisfied by the allotment and issue of mainly New Shares (approximately £4.3 million) and some cash (approximately £1.0 million, after the repayment of an inter-company loan of approximately £1.2 million) at completion ("Acquisitions"). The Acquisitions are in-line with the Company's strategy to increase its underwriting capacity, but also enables Nigel Hanbury and Arthur Manners to continue to invest in the Company, within the context of the Fundraising, further aligning themselves with the Company's shareholders. The Acquisitions are expected to constitute related party transactions for the purpose of the AIM Rules and will require specific shareholder approval and a statement from Shore Capital, the Company's nominated adviser, as to the fairness and reasonableness of the terms of Acquisitions.

 

Discussions are ongoing and remain at an early stage and a further announcement will be made in due course. There can be no certainty that the Fundraising and Acquisitions will be completed, nor as to the terms on which it may be achieved.

Nigel Hanbury, Chief Executive of Helios, commented:

"We are most encouraged by the progress we have made on the potential fundraising thus far, and by the significant interest we have seen from well-known and respected insurance specialist institutions.

"We remain convinced that this is a period of unprecedented opportunity for Helios, with a hardening market coupled with the opportunities we see to increase capacity from pre-emptions, make further LLV acquisitions and participate in capacity auctions, all of which would be value enhancing for our shareholders."

 

Market soundings, as defined in the Market Abuse Regulation ("MAR"), have been taken in respect of the proposed Fundraising, with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement and has been disclosed as soon as possible in accordance with paragraph 7 of Article 17 of MAR.

 

For further information, please contact:

 

Helios Underwriting plc

Nigel Hanbury - Chief Executive 07787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer 07754 965 917

 

Shore Capital

Robert Finlay 020 7408 4080

David Coaten

Henry Willcocks

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale 07872 604 453

020 7466 5111

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £70m of capacity for the 2020 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANEKESSEFFA
Date   Source Headline
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.